Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update.
Migraine and migraine variants are common, chronic and incapacitating neurovascular disorders with a high impact on health resources. There is an extensive evidence base provided by double-blind, placebo-controlled trials showing that topiramate is a safe, effective and well tolerated drug in the management of migraine and its variants, being especially promising in the management of migraine-vertigo syndrome. Models both in the US and the UK have also shown that it offers a cost benefit when direct and indirect costs are evaluated, by reducing work loss, improving quality of life and reducing the use of increasingly scarce health resources.
Carmona
Sergio
S
Department of Neuro-otology and Pain and Headache, Instituto de Neurociencias de Buenos Aires INEBA, Buenos Aires, Argentina;
Bruera
Osvaldo
O
Cephalalgia. 2007 Jul;27(7):814-23
17441971
Manag Care Interface. 2006 Dec;19(12):31-8
17274479
Headache. 2007 Mar;47(3):402-12
17371357
Neurology. 1992 Sep;42(9):1657-62
1513451
Headache. 1994 Jul-Aug;34(7):387-93
7928322
Headache. 1997 Nov-Dec;37(10):615-21
9439080
Brain. 2005 Feb;128(Pt 2):365-74
15601663
Neurology. 2004 Mar 9;62(5):788-90
15007133
Am J Med Genet. 2001 May 15;100(4):287-91
11343320
Headache. 2005 Apr;45 Suppl 1:S14-24
15833086
Am J Epidemiol. 1991 Nov 15;134(10):1111-20
1746521
Eur Neurol. 2007;58(4):215-7
17827966
Headache. 1993 Jan;33(1):29-35
8436495
Laryngoscope. 1992 Feb;102(2):135-8
1738284
Headache. 2005 Apr;45 Suppl 1:S66-73
15833092
Headache. 2001 Jul-Aug;41(7):638-45
11554951
Headache. 1992 Jun;32(6):300-4
1399552
Funct Neurol. 1986 Oct-Dec;1(4):363-6
3609866
Headache. 2004 Feb;44(2):174-6
14756858
JAMA. 2004 Jan 28;291(4):493-4
14747508
Headache. 2001 Jul-Aug;41(7):629-37
11554950
Nat Med. 2002 Feb;8(2):136-42
11821897
Headache. 2005 Apr;45 Suppl 1:S3-S13
15833088
Cephalalgia. 1995 Feb;15(1):22-5; discussion 4
7758093
Am J Dis Child. 1969 Apr;117(4):458-60
5773415
Curr Pain Headache Rep. 2008 Oct;12(5):333-7
18765137
Headache. 2008 Jul;48(7):1087-95
18687081
Neurology. 1996 Oct;47(4):871-5
8857711
Headache. 2001 Jul-Aug;41(7):646-57
11554952
Headache. 2007 Nov-Dec;47(10):1409-17
18052950
Clin Ther. 2008 Jun;30(6):1069-80
18640463
Cell. 1996 Nov 1;87(3):543-52
8898206
Am J Ther. 2004 Mar-Apr;11(2):130-40
14999365
Curr Pain Headache Rep. 2003 Apr;7(2):135-8
12628055
CNS Drugs. 2008;22(1):27-47
18072813
Headache. 1998 Feb;38(2):87-96
9529763
Headache. 1996 Feb;36(2):69-76
8742677
N Engl J Med. 2002 Jan 24;346(4):257-70
11807151
Neurol Sci. 2008 May;29 Suppl 1:S123-6
18545912
Neurology. 1999 Aug 11;53(3):537-42
10449117
Headache. 2007 Feb;47(2):170-80
17300356
Brain. 2004 Mar;127(Pt 3):526-34
14749288
Neurology. 2000 Sep 26;55(6):754-62
10993991
Headache. 2002 Sep;42(8):796-803
12390644
Headache. 2005 Apr;45 Suppl 1:S33-47
15833089
Clin Ther. 2008 Dec;30(12):2452-60
19167603
Neurology. 2001 Feb 27;56(4):436-41
11222783
Ann N Y Acad Sci. 2005 Apr;1039:517-20
15827012
Brain. 2005 Sep;128(Pt 9):2068-77
16006538
Ann N Y Acad Sci. 2002 Apr;956:338-45
11960817
Headache. 2001 Nov-Dec;41 Suppl 1:S3-10
11903534
Electroencephalogr Clin Neurophysiol. 1951 Aug;3(3):315-21
14879782
J Neurol. 1999 Oct;246(10):883-92
10552234
Cephalalgia. 2009 Apr;29(4):423-9
19170689
Cephalalgia. 2004;24 Suppl 1:9-160
14979299
JAMA. 2004 Jan 28;291(4):427-34
14747499
CNS Neurol Disord Drug Targets. 2007 Aug;6(4):247-50
17691980